Q4 Learning Session: OSU CarePoint Gahanna Family Medicine

Improvement and Team Members  Improvement: Increased utilization of

generic medications through therapeutic substitution.  Department of Family Medicine, Ohio State University Wexner Medical

Center.   

Emily Vrontos, PharmD, CDE Bella Mehta, Pharm.D. Director, Clinical Partners Program Randy Wexler MD MPH FAAFP. Clinical Vice Chair

 The Ohio State University Health Plan 

Bruce Wall MD, Medical Director of The Ohio State University Health Plan

Plan  Co-creation between a health plan and

providers of a clinical program that adds value to the member/patients it serves (value defined as the quality of care divided by the overall cost of care).  Identify and maximize the respective strengths among both organizations to realize maximum efficiency and effectiveness. 

Plan-actionable data/Providers-relationship with patient

Do  Pharmacist reviewed therapeutic cost savings opportunities 

Recommended to prescriber if appropriate

 PCN data: 

46% of claims recommended to physician, 61% accepted, 45% documented change

 Clinical Partners data:  

Gahanna: 63% of claims recommended to physician, 91% accepted by physician, 41% accepted by patients Lewis Center: 44% of claims recommended to physician, 29% accepted by physician, 0% accepted by patients

Study  Lessons learned   

Prepare providers ahead of time.

Provide the names of those who will be contacting providers Inform staff as well as physicians

 Ensure complete documentation present in patient

chart Reduces unnecessary time that can be dedicated to other pursuits – Include intolerances/adverse effects in allergies or specialty comments



Act  Understand variance of uptake by site  Expand process to multiple payers  Enhance evaluation and management of high

risk patients  Improve medication regimen concordance

following hospital and ED discharge